Research Article
Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program
Table 4
Calculated age-specific incidence rates, crude rates, and ASR (World), females, Egypt 2008–2011.
| | Site | 0–4 | 5–9 | 10–14 | 15–19 | 20–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45–49 | 50–54 | 55–59 | 60–64 | 65–69 | 70–74 | 75+ | Crude rate | ASR | % |
| | Lip | — | — | — | — | — | — | — | — | 0.3 | 1.4 | 0.8 | 0.5 | 1.6 | 0.8 | 1.3 | 4.7 | 0.2 | 0.4 | 0.21% | | Tongue | — | — | — | — | — | 0.5 | — | — | — | 0.4 | 0.4 | 1.2 | 0.7 | — | — | 15.4 | 0.3 | 0.5 | 0.26% | | Mouth | — | 0.1 | 0.1 | — | — | — | — | — | 0.3 | 1.0 | 0.8 | 0.5 | 1.4 | 2.9 | 6.1 | 2.7 | 0.3 | 0.5 | 0.28% | | Salivary glands | — | — | 0.3 | — | — | — | — | — | — | 0.7 | — | 2.9 | 0.7 | 2.9 | — | — | 0.2 | 0.3 | 0.18% | | Tonsil | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.2 | — | 1.4 | — | 0.1 | 0.04% | | Other oropharynx | — | — | — | — | — | — | — | — | — | 0.3 | — | 0.7 | — | 0.8 | — | — | — | 0.1 | 0.04% | | Nasopharynx | 0.1 | — | 0.1 | — | — | — | — | — | — | — | — | — | 1.6 | — | — | — | 0.1 | 0.1 | 0.06% | | Hypopharynx | — | — | — | — | — | 0.2 | — | 0.4 | 0.3 | 1.0 | 0.9 | 0.5 | — | 1.1 | — | — | 0.2 | 0.2 | 0.16% | | Pharynx unspec. | — | — | — | — | — | 0.2 | — | — | — | — | — | — | — | — | — | — | — | — | 0.01% | | Esophagus | — | — | — | — | — | 0.2 | — | — | 2.0 | 1.3 | 0.8 | 3.7 | 11.1 | 10.6 | 9.2 | 5.4 | 0.9 | 1.5 | 0.79% | | Stomach | — | 0.1 | — | — | — | — | 2.0 | 1.4 | 3.1 | 5.1 | 5.7 | 5.1 | 9.7 | 16.3 | 18.7 | 14.8 | 1.8 | 2.7 | 1.65% | | Small intestine | — | — | — | — | — | — | — | 0.4 | — | 1.9 | 1.7 | — | 1.4 | 5.2 | 4.8 | — | 0.4 | 0.5 | 0.32% | | Colon | — | — | — | — | 0.5 | 0.5 | 1.0 | 2.4 | 2.9 | 7.9 | 9.4 | 7.9 | 10.4 | 25.2 | 16.2 | 29.4 | 2.5 | 3.8 | 2.28% | | Rectum | — | — | — | — | 0.1 | 1.1 | 1.2 | 0.7 | 1.9 | 1.7 | 1.9 | 2.9 | 3.0 | 3.9 | 4.4 | 5.4 | 0.8 | 1.1 | 0.72% | | Anus | — | — | — | — | — | 0.2 | — | — | 0.3 | — | 0.5 | — | 1.6 | — | 1.3 | — | 0.1 | 0.1 | 0.09% | | Liver | 1.0 | — | 0.5 | — | — | 0.9 | 2.0 | 3.3 | 12.5 | 25.2 | 43.2 | 89.3 | 129.3 | 143.9 | 167.9 | 150.4 | 15.1 | 24.4 | 13.54% | | Gallbladder and so forth | — | — | — | — | 0.3 | — | 0.5 | 0.5 | 0.3 | 1.3 | 2.5 | 3.3 | 2.2 | 3.7 | 6.9 | 6.0 | 0.6 | 0.9 | 0.55% | | Pancreas | — | — | — | — | — | 0.4 | — | 0.5 | 0.6 | 3.0 | 3.4 | 8.6 | 9.0 | 18.7 | 24.4 | 19.5 | 1.6 | 2.6 | 1.41% | | Nose, sinuses and so forth | 0.1 | — | — | — | — | — | — | — | 0.3 | 0.7 | 1.2 | 1.2 | 5.4 | — | — | — | 0.3 | 0.4 | 0.23% | | Larynx | — | — | — | — | — | — | — | — | 0.3 | 1.0 | 2.0 | — | 3.0 | — | 3.0 | 2.1 | 0.3 | 0.4 | 0.23% | | Trachea, Bronchus, Lung | 0.7 | — | 0.1 | 0.1 | 0.5 | 2.0 | 1.0 | 1.5 | 1.7 | 6.9 | 12.3 | 11.7 | 15.1 | 11.3 | 35.9 | 38.0 | 3.0 | 4.5 | 2.70% | | Other Thoracic organs | — | — | — | — | — | — | — | — | 0.8 | 1.7 | 1.6 | 2.6 | 1.6 | 3.0 | 1.3 | 10.7 | 0.5 | 0.7 | 0.42% | | Bone | 0.7 | 0.1 | 1.1 | 2.0 | 1.4 | 0.7 | 0.7 | 2.2 | 0.9 | 2.3 | 6.5 | 6.7 | 12.0 | 4.5 | 2.6 | 16.9 | 2.0 | 2.5 | 1.80% | | Melanoma of skin | — | — | — | — | — | — | — | — | 0.6 | — | — | — | — | 2.2 | 4.4 | — | 0.1 | 0.2 | 0.10% | | Other skin | 0.3 | — | — | 0.2 | — | 0.4 | 0.5 | — | 2.0 | 2.7 | 1.2 | 8.6 | 10.4 | 14.0 | 14.9 | 11.8 | 1.4 | 2.2 | 1.24% | | Mesothelioma | — | — | — | — | — | — | — | — | — | — | 1.2 | 0.5 | 3.0 | 1.1 | 4.8 | — | 0.2 | 0.3 | 0.17% | | Kaposi sarcoma | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.8 | — | — | — | — | 0.01% | | Connective, Soft tissue | 1.2 | 0.3 | 0.7 | 0.4 | 1.5 | 2.1 | 1.7 | 1.2 | 2.0 | 2.0 | 2.9 | 2.4 | 6.2 | 3.9 | 3.1 | 13.4 | 1.6 | 1.9 | 1.42% | | Breast | — | — | — | — | 3.1 | 9.5 | 29.2 | 49.0 | 86.0 | 106.2 | 136.0 | 172.9 | 177.4 | 166.3 | 138.7 | 148.6 | 35.8 | 48.8 | 32.04% | | Vulva | 0.1 | — | 0.1 | — | — | — | — | — | — | 0.3 | — | 1.0 | — | 0.8 | — | 1.4 | 0.1 | 0.1 | 0.09% | | Vagina | — | — | — | — | — | — | — | — | — | — | — | 1.0 | 3.0 | 3.3 | — | 1.4 | 0.2 | 0.3 | 0.14% | | Cervix Uteri | — | — | — | — | — | 0.2 | 0.2 | — | 0.6 | 3.6 | 6.5 | 9.1 | 8.3 | 10.5 | 1— | 9.4 | 1.3 | 2.0 | 1.17% | | Corpus Uteri | — | — | — | — | — | — | 0.5 | 0.2 | 0.6 | 1.3 | 0.7 | 8.1 | 4.3 | 3.0 | 3.0 | 12.1 | 0.7 | 1.1 | 0.62% | | Uterus unspec. | — | — | — | 0.5 | 1.2 | 0.4 | 0.7 | 0.5 | 1.8 | 1.6 | 11.1 | 9.5 | 21.5 | 20.4 | 31.4 | 21.2 | 2.5 | 3.9 | 2.27% | | Ovary | — | — | 0.5 | 0.4 | 0.8 | 1.5 | 1.5 | 3.3 | 8.7 | 17.2 | 20.3 | 24.0 | 19.6 | 17.2 | 2— | 26.3 | 4.6 | 6.3 | 4.12% | | Other female genital | — | — | — | — | — | — | — | 0.3 | — | — | — | — | — | — | 1.3 | 2.1 | 0.1 | 0.1 | 0.05% | | Placenta | — | — | — | — | — | 0.4 | — | — | — | — | — | — | — | — | — | — | — | — | 0.03% | | Kidney | 1.5 | 0.1 | — | — | — | 0.5 | 0.8 | 0.5 | 0.6 | 2.9 | 2.3 | 1.0 | 10.4 | 10.7 | 1.3 | 7.3 | 1.1 | 1.6 | 0.97% | | Renal pelvis | — | 0.3 | — | — | — | 0.6 | — | 0.2 | — | 0.7 | 0.4 | 0.5 | 1.6 | 0.8 | — | — | 0.2 | 0.3 | 0.19% | | Ureter | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.00% | | Bladder | 0.1 | — | — | 0.2 | — | 0.2 | — | 0.7 | 0.8 | 5.3 | 8.2 | 18.6 | 20.2 | 37.8 | 43.6 | 53.9 | 3.3 | 5.5 | 2.96% | | Other urinary organs | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.2 | — | — | — | 0.1 | 0.03% | | Eye | 0.1 | 0.3 | — | — | — | — | 0.5 | — | — | — | — | 1.2 | 0.7 | 0.8 | — | 1.4 | 0.2 | 0.2 | 0.14% | | Brain, Nervous tissue | 3.3 | 2.1 | 1.9 | 0.8 | 2.9 | 0.7 | 4.5 | 6.5 | 6.6 | 9.5 | 11.3 | 12.1 | 31.4 | 26.3 | 33.1 | 72.2 | 5.8 | 8.0 | 5.18% | | Thyroid | — | — | — | — | 2.7 | 2.8 | 10.2 | 7.2 | 6.4 | 9.7 | 10.2 | 11.0 | 9.0 | 2.6 | 10.4 | 14.2 | 3.7 | 4.3 | 3.28% | | Adrenal gland | 1.5 | 0.1 | — | — | — | — | — | — | — | — | — | 1.2 | — | — | — | 1.4 | 0.2 | 0.3 | 0.20% | | Other endocrine | — | 0.1 | — | 0.1 | 0.1 | 0.3 | — | 0.5 | 0.3 | 0.3 | 0.4 | 1.0 | 0.7 | 0.8 | — | — | 0.2 | 0.2 | 0.19% | | Hodgkin disease | — | 0.6 | 0.4 | 1.9 | 1.3 | 0.4 | 1.2 | 0.7 | 0.6 | 0.4 | — | 1.2 | 3.8 | — | — | — | 0.8 | 0.8 | 0.70% | | Non-Hodgkin lymphoma | 0.9 | 0.7 | — | 1.1 | 0.8 | 1.2 | 1.7 | 3.3 | 3.8 | 8.6 | 16.0 | 23.4 | 24.1 | 16.8 | 31.3 | 36.7 | 4.2 | 6.1 | 3.80% | | Immunoproliferative dis. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.00% | | Multiple myeloma | — | — | — | — | — | — | — | — | 0.6 | 1.4 | 0.8 | 1.2 | 2.3 | 4.4 | 6.1 | 2.7 | 0.4 | 0.6 | 0.34% | | Lymphoid leukemia | 2.0 | 0.7 | 0.9 | 0.4 | 0.5 | — | 0.7 | 0.7 | 1.4 | 1.0 | 2.7 | 1.7 | 2.8 | 3.9 | 4.4 | — | 1.0 | 1.2 | 0.93% | | Myeloid Leukemia | 0.5 | 0.3 | 0.7 | 0.2 | 1.5 | 1.5 | 1.4 | 1.0 | 0.9 | 0.7 | 4.0 | 3.1 | 6.8 | 7.5 | — | 4.9 | 1.3 | 1.6 | 1.14% | | Leukemia unspec. | 0.4 | 0.7 | 0.7 | 1.3 | 0.9 | 1.7 | 1.5 | 0.7 | 1.4 | 2.7 | 3.3 | 5.5 | 6.1 | 8.3 | 7.4 | 14.8 | 1.7 | 2.2 | 1.55% | | Other & unspecified | 1.4 | 0.9 | 1.9 | 1.7 | 2.4 | 3.9 | 4.6 | 5.5 | 9.6 | 12.5 | 23.8 | 37.3 | 39.9 | 42.1 | 42.6 | 70.5 | 7.7 | 10.8 | 6.93% |
| | All sites Total | 16.1 | 7.8 | 10.1 | 11.4 | 22.4 | 34.9 | 69.7 | 95.2 | 163.7 | 255.3 | 359.1 | 506.5 | 633.7 | 665.8 | 715.9 | 850.5 | 111.7 | 159.1 | 100.00% | | All sites but C44# | 15.8 | 7.8 | 10.1 | 11.2 | 22.4 | 34.6 | 69.3 | 95.2 | 161.6 | 252.5 | 357.9 | 497.8 | 623.3 | 651.8 | 701.0 | 838.7 | 110.3 | 157.0 | 98.76% |
|
|
Incidence rates do not include nonmelanoma skin cancer.
|
